Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

iTherX Appoints Stefan Zeuzem, M.D., as Chair of Scientific and Clinical Advisory Board

March 15, 2011 By Bio-Medicine.Org

SAN DIEGO, March 15, 2011 /PRNewswire/ — iTherX, a
pharmaceutical company dedicated to discovering and developing a
new class of therapies for hepatitis C, today announced that Stefan
Zeuzem, M.D., has joined the company as Chair of the Scientific and
Clinical Advisory Board.  Dr. Zeuzem will lead a respected
group of hepatitis thought leaders in contributing their expertise
to the clinical development of iTherX’s lead compound, ITX-5061, a
first-in-class hepatitis C entry inhibitor.

“Stefan Zeuzem brings more than 20 years of international
clinical and research leadership in hepatitis viruses, as well as
liver disease and transplantation to our team. iTherX is fortunate
to have Dr. Zeuzem’s invaluable guidance and perspective as we
advance our lead compound ITX-5061, a hepatitis C viral entry
inhibitor, through clinical development,” said Flossie Wong-Staal,
Ph.D., Chief Scientific Officer of iTherX.  “We have
established a truly dynamic and experienced scientific and clinical
advisory board to bring forward this novel class of compounds.
 Along with our advisors, we believe ITX-5061 has the promise
of preventing the entry of the hepatitis C virus into cells while
complementing existing antiviral treatment.”

Dr. Zeuzem currently serves as Chief of the Department of
Medicine and Professor of Medicine at the Johann Wolfgang Goethe
University Hospital in Frankfurt, Germany. His clinical areas of
expertise include gastroenterology, hepatology, liver
transplantation, endoscopy, gastrointestinal oncology, and
endocrinology. Dr. Zeuzem’s current research interests include
cellular physiology, molecular biology of hepatitis viruses, viral
kinetics, the role of hepatitis viruses in hepatocarcinogenesis,
and the stratification and optimization of antiviral treatment.
After receiving his medical training from the J.W. Goethe
University Medical School, the University Of Cambridge School Of
Clinical Medicine (United Kingdom), and the Univ

‘/>”/>

SOURCE

Related Articles Read More >

TE Connectivity opens global medical device prototyping center in Ireland
Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech